Pacira Pharmaceuticals buy tamam
Start price
26.07.18
/
50%
€34.50
Target price
01.08.19
€52.32
Performance (%)
14.75%
End price
01.08.19
€39.59
Summary
This prediction ended on 01.08.19 with a price of €39.59. The BUY prediction by tamam finished with a performance of 14.75%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pacira Pharmaceuticals | -7.216% | -7.216% | -45.122% | -63.265% |
| iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
| iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
| iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
| iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by tamam for this prediction
In the thread Pacira Pharmaceuticals diskutieren
tamam stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
tamam stimmt am 26.07.2018 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu.
(Laufzeit überschritten)